Moderna Inc (MRNA)
Return on assets (ROA)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | -3,561,000 | -2,224,000 | -5,867,000 | -5,968,000 | -4,714,000 | -3,466,000 | 1,207,000 | 4,784,000 | 8,362,000 | 11,765,000 | 14,055,000 | 14,638,000 | 12,202,000 | 7,061,515 | 3,494,879 | 598,166 | -747,064 | -598,819 | -488,377 | -506,718 |
| Total assets | US$ in thousands | 14,142,000 | 15,803,000 | 15,680,000 | 16,729,000 | 18,426,000 | 19,450,000 | 21,884,000 | 24,125,000 | 25,858,000 | 26,056,000 | 26,043,000 | 27,609,000 | 24,669,000 | 20,923,000 | 16,153,000 | 12,694,000 | 7,337,000 | 4,650,870 | 3,486,010 | 2,067,540 |
| ROA | -25.18% | -14.07% | -37.42% | -35.67% | -25.58% | -17.82% | 5.52% | 19.83% | 32.34% | 45.15% | 53.97% | 53.02% | 49.46% | 33.75% | 21.64% | 4.71% | -10.18% | -12.88% | -14.01% | -24.51% |
December 31, 2024 calculation
ROA = Net income (ttm) ÷ Total assets
= $-3,561,000K ÷ $14,142,000K
= -25.18%
Based on the provided data, Moderna Inc's return on assets (ROA) has experienced significant fluctuations over the examined period from March 31, 2020, to December 31, 2024.
The ROA started at a concerning level of -24.51% as of March 31, 2020, suggesting that the company was not efficiently utilizing its assets to generate profits. This negative trend continued into the subsequent quarters, with ROA improving slightly but remaining negative up to December 31, 2020.
The turnaround began in the first quarter of 2021, with ROA reaching a positive 4.71%, indicating Moderna Inc was starting to generate profits more efficiently relative to its assets. The positive momentum carried through the next quarters, exhibiting significant improvements in ROA performance by June 30, 2021 (21.64%), September 30, 2021 (33.75%), and December 31, 2021 (49.46%).
The trend continued with ROA peaking at 53.97% as of June 30, 2022, indicating Moderna Inc's asset utilization was highly effective at that point. However, the following periods saw a gradual decline in ROA, dropping to 19.83% by March 31, 2023, and turning negative again by the end of 2023.
The downward trajectory persisted into 2024, with Moderna Inc experiencing negative ROA values, reaching its lowest point at -37.42% on June 30, 2024. By December 31, 2024, ROA improved slightly to -25.18%, but the overall trend in the latter part of the analysis period was unfavorable.
In conclusion, the analysis of Moderna Inc's ROA reveals a volatile performance, characterized by periods of both significant improvement and decline. It highlights the company's varying levels of efficiency in generating profits from its assets over the years under review.
Peer comparison
Dec 31, 2024